Catalyst
Slingshot members are tracking this event:
GW Pharma's (GWPH) Phase 2 Data Evaluating Sativex in Children with Spasticity due to Cerebral Palsy Expected in Q1 2017
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| GWPH |
|
|
||||
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
May 16, 2017
Occurred Source:
https://clinicaltrials.gov/archive/NCT01898520/2017_05_16/changes
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Sativex, Spasticity, Cerebral Palsy, Children, Data Release, Phase 2
